Environmental, Social and
Governance (ESG) Program

Cryoport calculates its greenhouse gas (GHG) emissions in accordance with the World Resource Institute’s Greenhouse Gas Protocol – Corporate Accounting and Reporting Standard (Revised Edition), a globally recognized framework for measuring, managing, and reporting GHG emissions. The standard provides accounting tools to measure, manage, and report on GHG emissions. This protocol classifies emissions into three “scopes.”

Scope 1 emissions include direct GHG emissions, which occur from sources that are owned or controlled by a company.

Scope 2 emissions include indirect GHG emission from purchased electricity.

Scope 3 emissions encompass all other indirect emissions generated throughout the Company’s value chain. 

Some of the Scope 3 emissions that contribute to our global carbon footprint, but for which we determined that data was not reasonably available for us to quantify in this report include, but are not limited to: transportation and distribution provided by third parties in the performance of our services; use and end-of-life treatment of sold products; and purchased goods and services. 

Safety is a priority in every aspect of our business. Across our companies, we are committed to making our workplaces and communities safer for our employees, customers, and the public. Our corporate philosophy is embedded in our day-to-day work through policies and continual education.  

Cryoport’s Employee Health & Safety (EHS) programs have consistently demonstrated strong safety performance, as evidenced by our total injury rates (TIR) and lost time injury rates (LTIR) being significantly lower than the global industry averages. Guided by our culture of continuous improvement and operational excellence, we are committed to further strengthening workplace safety initiatives and continuing to further reduce our TIR and LTIR metrics across our global operations. 

To understand and improve our safety performance, we measure our operational performance across a variety of indicators—including lost-time-injury rate (LTIR)—on a daily basis. In 2025, our LTIR for our United States operations was 0.41. In addition to looking at past indicators of safety performance, we frequently evaluate the effectiveness of new metrics, including leading indicators, as we strive to improve our safety performance. Cryoport’s operating companies are responsible for implementing policies and procedures aligned with international standards that account for their business and the associated health and safety risks.  

As a temperature-controlled supply chain provider to the life sciences industry, Cryoport must comply with the safe transportation of regulated hazardous materials. As a result, we have designed and developed several features in its various products to comply with US DOT, IATA, ICAO, and other regulatory and guidance bodies. Additionally, safety warnings are included in our product labeling as well as our manuals. Our products are designed to conform to various standards, including from among the following (where applicable): 

• ISO 13485 (Section 7.3 Design and Development, ISO, QMS) 

• ISO 14971 Application of Risk Management, ISO 

• Medical Device Directive Medical Devices Directive 93/42/EEC, and Directive 2007/47/EC amending Council Directive 93/42/EEC concerning medical devices 

• Low Voltage Directive (LVD) (2014/35/EU) 

• Electromagnetic Compatibility Directive (2014/30/EU) 

• RoHS 2 (2011/65/EU) (we are actively working on RoHS 3 and REACH) 

• Safety Requirements For Electrical Equipment For Measurement, Control, And Laboratory Use – Part 1: 

• General Requirements [UL 61010-1:2012 Ed.3+R:29Apr2016] 

• Safety Requirements For Electrical Equipment For Measurement, Control, And Laboratory Use – Part 1: 

• General Requirements (R2017) [CSA C22.2#61010-1-12:2012 Ed.3+U1; U2] 

• IEC 60601-1 – Medical electrical equipment – Part 1: General requirements for basic safety and essential performance 

• IEC 61326-1:2012 – Electrical Equipment For Measurement, Control And Laboratory Use – EMC Requirements – Part 1: General Requirements 

• ASME SEC. VIII Pressure Vessel Code (Fusion Only) 

• EU Pressure Equipment Directive (EU97/23/EC) (Fusion Only) 

• FCC 47 CFR Class B Verification (Fusion Only) 

• IEC 62304 Medical device software — Software life cycle processes 

These standards are integrated into our development methodology used to design new products and services within our company. The development process includes a risk management assessment done in accordance with ISO 14971 that identifies hazards and mitigates risks via design improvements, process improvements, and warnings (including labels and safety information shipped with the product). 

We take pride in delivering exceptional operational quality across our temperature-controlled supply chain solutions. We estimate that cell and gene therapy-focused solutions achieved a 99.60% delivery success rate over 2024 and 2025 and, due to this performance, we estimate that 26,282 additional patients were able to receive therapies during that period. In addition, we estimate that our CryoStork® solution had a 99.98% delivery success rate in 2025. Based on this performance, we estimate that approximately 2,162 intended parents may have had the opportunity for successful fertility treatment cycles resulting in the birth of a child through the reliable transport and handling provided by the CryoStork® solution in 2025.  

While rare, recalls of products may become necessary. The primary responsibility for recall management lies with our Vice President of Quality Assurance and Regulatory Affairs for manufacturing. The executive team is involved in the decision and implementation processes depending upon the specifics of any recall that may be required. Customer service personnel, sales staff and other resources would then be utilized to reach all distributors and direct end users. The results of recalls are evaluated daily until the recall is closed. There were no product recalls during 2025. 

Cryoport’s unique products are developed with long-term use in mind. Cryoport’s products are primarily constructed of recyclable aluminum or stainless steel, and we approach the extension of product lifecycles through the following four areas: 

• Longevity 

• Reparability 

• Reusability 

• Recyclability  

We strive to design and manufacture products with long operational life spans and, where possible, to help minimize the environmental impact associated with the production and replacement of new equipment. At our MVE Biological Solutions production facility, in 2025, we manufactured cryogenic freezer units that we estimate utilize approximately 0.008 of the energy used by conventional mechanical freezers used for similar applications. For example, our freezer production displaced annual electricity consumption by 96,182,622 kWh from what would otherwise be consumed from alternative products. This amount of electricity could power 9,375 homes annually. This reduction in energy consumption from our freezer lines alone equates to 74.2 million pounds of avoided GHG emissions, equivalent to removing 7,846 passenger vehicles from the road for one year. 

Cryoport regularly reviews opportunities to eliminate the use of materials considered hazardous and related managed waste streams. Cryoport does not utilize any substances of concern in our products; we do currently utilize minimal quantities of hazardous materials that are not listed as substances of concern in our operations, primarily in the form of isopropanol, epoxies, butyl cellosolve, lacquer thinner, paint, hyamine and isopropyl alcohol. These materials and the insignificant quantities of hazardous wastes generated by our production facilities are managed in compliance with all state and federal regulations. Any hazardous waste that is generated is tracked and managed with an overall goal of eliminating hazardous materials where possible.  Cryoport strives to have a conflict-free supply chain and is committed to working with its suppliers to increase transparency regarding the origin of minerals contained in its products, including minerals identified as conflict minerals (tin, tungsten, tantalum, and gold), and has adopted a Conflict Minerals Policy, which is  available on our website at www.cryoportinc.com on the “Investor Relations: Governance” page under the heading “Governance Documents.” 

We are committed to operating with honesty and transparency in accordance with the highest ethical and corporate governance standards – mutual respect, integrity and trust are the foundation of our company. Our Code of Ethical Business Conduct (the “Code of Ethics”) serves as the foundation of our corporate integrity and compliance program and applies to our directors and all employees, including our Chief Executive Officer and Chief Financial Officer.  The Code of Ethics is available on our website at www.cryoportinc.com on the “Investor Relations: Governance” page under the heading “Governance Documents.”  All employees across our operations are provided with training and reference materials to reinforce this commitment to integrity and ethics in our business.  Our Code of Ethics is translated into local languages for our employees where applicable and includes guidance on topics including, but not limited to the following: 

• Corruption 

• Anti-Trust and Anti-Competitive Behavior 

• Insider Dealings 

• Gifts 

• Bribes (e.g., explicit prohibition of facilitation payments) 

• Conflicts of Interest 

• Intellectual Property 

• Regulatory Compliance 

• Truthful and Accurate Reporting 

• Human Rights 

• Equal Employment Opportunity  

• Anti-harassment 

• Environmental Compliance and Sustainability  

• Whistleblower protections (including non-retaliation) 

• Political Activity and Contributions (e.g., explicit prohibition of contribution of any kind to any candidate or political party without express prior approval of our board of directors – this covers both direct contributions and indirection support; no political contributions have been made in recent years) 

• Reporting Violations of Company Policy 

Our officers, directors, and managers are responsible for promoting the principles within the Code of Ethics and fostering a culture of ethical conduct. Our commitment to doing the right thing depends on our employees’ being comfortable in reporting any suspected violations of law or unethical conduct, and our leaders’ abilities to address suspected violations promptly, with respect. Our global policy against retaliation encourages employees to come forward to report concerns in good faith. When a matter is reported to a manager or our HR department, the concern is reviewed to determine whether it should be escalated to the legal department. The legal department also has criteria for further escalation, if necessary, to legal department management.  Every new employee is introduced to the Code of Ethics through training and orientation.  

We develop and update these policies when we identify a need for employee clarification, the emergence of new laws or regulations, or other external factors. We routinely review and update the language in our policies, and how we present information, to ensure our employees understand the risks they face in their jobs, and steps they can take to mitigate those risks and report potential problems. 

Our commitment to human rights is an important part of the Code of Ethics. We are committed to protecting and advancing human rights in our operations around the world. We pay fair wages and comply with wage laws in all the countries where we operate. We prohibit the use of child, compulsory, or forced labor, and we share the zero-tolerance policies adopted by the United States and other governments against slavery and human trafficking. We prohibit the trafficking of persons for any purpose and trafficking-related activities, and we expect the same from our suppliers and vendors. 

In addition to our Code of Conduct, our senior leadership team actively oversees the governance of our ethics programs to help ensure that commitment is driven from the top down, and that program owners are accountable for successful program compliance.  

Cryoport does not conduct clinical trials, perform animal testing, or use human tissue of any kind in the design, development, or manufacture of its products. Our Code of Conduct governs the ethical behavior of our employees across all of Cryoport’s global operations. In addition, Cryoport does not engage in lobbying activities. 

Temperature-controlled supply chain support to the life sciences industry is critical to all that Cryoport does; therefore, we take an active approach to managing suppliers and partners to ensure that appropriate compliance, health, safety, labor practices, and ethical standards are employed. Our internal diligence process for third-party vendors includes a supplier questionnaire that is required for vendor approval and a regular auditing process thereafter for existing suppliers. The questionnaire is intended to verify that our suppliers have programs in place to manage material risk areas associated with the given supplier’s operations and particular consideration is paid to bribery or other forms of corrupt activity. Suppliers are not approved until this mandatory due diligence is complete and a completed assessment form is on file. 

As an example, if one of our transportation suppliers employs or works with a Dangerous Goods Safety Advisor, we confirm the presence of a credentialed role responsible for overseeing activities associated with dangerous goods, including but not limited to, employee training and coaching, reporting, and monitoring of activities associated with the transportation of dangerous goods. The purpose of this inquiry is to gauge the degree of oversight over dangerous goods management by our suppliers to help ensure product and employee welfare. 

Our Code of Conduct extends throughout our approved suppliers and thus sets an expectation for our suppliers to commit to operating with honesty, truthfulness and transparency in accordance to the highest ethical and corporate governance standards, as Cryoport personifies through our operations. Per our Code of Conduct, Cryoport will not tolerate the use by suppliers of forced labor in any form. 

Cryoport uses an outside Center for Internet Security (CIS) assessment firm to evaluate our data security controls in an effort to protect our businesses and secure the information of our employees and customers. The CIS evaluation process utilizes the CIS’ Critical Security Controls Capability Maturity Model Integration (CMMI) methodology, and is an ongoing initiative used to continuously improve the CMMI rating for the Company. 

Our customers rely on Cryoport to securely and reliably deliver temperature-controlled supply chain solutions globally, including providing a secure online portal for order entry, tracking, condition monitoring, and for the retrieval of historic information. Protecting the privacy of our customers and suppliers is essential to maintaining their trust, and we take a proactive approach to safeguard all data and ensure a secure environment. With the increasing presence and sophistication of online threats, we strive for continuous improvements that aim to protect our business and our customers. We regularly review our technology, policies, and practices to maintain compliance with all relevant global regulations. We do not sell customers’ data to third parties. Additionally, Cryoport employees with a computer are required to complete an annual online training courses on information security and data privacy. The courses address a range of topics related to information security and data privacy, including awareness regarding social engineering and cybercrimes, protecting the workplace, and protecting data. 

Our Code of Ethical Business Conduct (the “Code of Ethics”) applies to our directors and all employees, including our Chief Executive Officer and Chief Financial Officer and is available on our website at www.cryoportinc.com on the “Investor Relations: Governance” page under the heading “Governance Documents.”

The Code of Ethics serves as the foundation of our corporate integrity and compliance program. Our officers, directors, and managers are responsible for promoting the principles within the Code of Ethics and fostering a culture of ethical conduct. We regularly review and update the Code of Ethics to ensure it remains relevant and available to our global employees. The Code of Ethics covers a breadth of topics, including conflicts of interest, equal employment opportunity and anti-harassment, environmental compliance and sustainability, insider trading rules, and how to report violations of Company policies. Our commitment to doing the right thing depends on our employees’ being comfortable in reporting any suspected violations of law or unethical conduct, and our leaders’ abilities to address suspected violations promptly, with respect. Our global policy against retaliation encourages employees to come forward to report concerns in good faith. When a matter is reported to a manager or our HR department, the concern is reviewed to determine whether it should be escalated to the legal department. The legal department also has criteria for further escalation, if necessary, to legal department management.  Every new hire is introduced to the Code of Ethics through training and orientation.

We develop and update these policies when we identify a need for employee clarification, the emergence of new laws or regulations, or other external factors. We routinely update the language in our policies, and how we present information, to ensure our employees understand the risks they face in their jobs, and steps they can take to mitigate those risks and report potential problems.

Our commitment to human rights is an important part of the Code of Ethics. We are committed to protecting and advancing human rights in our operations around the world. We pay fair wages and comply with wage laws in all the countries where we operate. We prohibit the use of child, compulsory, or forced labor, and we share the zero-tolerance policies adopted by the United States and other governments against slavery and human trafficking. We prohibit the trafficking of persons for any purpose and trafficking-related activities, and we expect the same from our suppliers and vendors.